Joshua Frommeyer

Joshua Frommeyer has been working in the scientific field since 2018. Joshua'sfirst position was a Research Intern at Thomas More University. In 2018, they also began working as a Research Assistant at Eckerd College. In 2019, they completed a Research Internship at Massachusetts General Hospital. In 2021, Joshua began working as an Associate Scientist at KSQ Therapeutics, Inc. and also took on a Research Assistant role at Eckerd College, where they worked on CPD-188, a STAT-3 inhibitor, and a literature review on dopamine transporter (DAT) antagonists. In 2022, Joshua started working as an Analytical/Formulation Laboratory Technician at Bexion Pharmaceuticals.

Joshua Frommeyer began their educational career in 2015 when they received their High School Diploma from Morehead State University, where they studied Biology, General. Joshua then attended the University of Cincinnati from 2017 to 2018, graduating with a Bachelor of Science in Zoology/Animal Biology. Currently, Joshua is enrolled at Eckerd College, where they are pursuing a degree in Biochemistry with a focus on Organic Chemistry.